κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis

Beel, Stephanie; Kolloch, Lina; Apken, Lisa; Jürgens, Lara, Bolle, Andrea; Sudhof, Nadine, Ghosh, Sankar; Wardelmann, Eva; Meisterernst, Michael; Steinestel, Konrad; Oeckinghaus, Andrea

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Pancreatic ductal adenocarcinoma (PDAC) is associated with high mortality and therapy resistance. Here, we show that low expression of κB-Ras GTPases is frequently detected in PDAC and correlates with higher histologic grade. In a model of KRasG12D-driven PDAC, loss of κB-Ras accelerates tumour development and shortens median survival. κB-Ras deficiency promotes acinar-to-ductal metaplasia (ADM) during tumour initiation as well as tumour progression through intrinsic effects on proliferation and invasion. κB-Ras proteins are also required for acinar regeneration after pancreatitis, demonstrating a general role in control of plasticity. Molecularly, upregulation of Ral GTPase activity and Sox9 expression underlies the observed phenotypes, identifying a previously unrecognized function of Ral signalling in ADM. Our results provide evidence for a tumour suppressive role of κB-Ras proteins and highlight low κB-Ras levels and consequent loss of Ral control as risk factors, thus emphasizing the necessity for therapeutic options that allow interference with Ral-driven signalling.

Details zur Publikation

FachzeitschriftNature Communications
Jahrgang / Bandnr. / Volume11: 3409
StatusVeröffentlicht
Veröffentlichungsjahr2020
StichwörterPancreatic cancer, Growth factor signalling, Mechanisms of disease

Autor*innen der Universität Münster

Apken, Lisa Helene
Institut für Molekulare Tumorbiologie
Beel, Stephanie
Institut für Molekulare Tumorbiologie
Kolloch, Lina Jenny
Medizinische Klinik A (Med A)
Meisterernst, Michael
Institut für Molekulare Tumorbiologie
Oeckinghaus, Andrea Marion
Institut für Molekulare Tumorbiologie
Wardelmann, Eva Erika
Gerhard-Domagk-Institut für Pathologie